Every few years, drug development goes through a moment where a new technology promises to change everything. Artificial ...
An AI-powered imaging tool developed by Brainomix has been used to enrich data from a phase 2a trial of Endeavor BioMedicines ...
Registration and the full programme are available on the DIA-MHRA Global Summit page. Follow the conversation at ...
Speaking to investors and analysts at its capital markets day in London, UK, Sandoz presented its new strategy – Bio100 – ...
At present, the only FDA-approved oral therapies for HAE are BioCryst's Orladeyo (berotralstat) and KalVista Pharma's Ekterly ...
It's well-established that breathing exercises can improve symptoms in COPD by freeing stale air that remains trapped in the ...
Uniting leaders pioneering complement-targeted therapies across ophthalmology, neurodegeneration, nephrology, oncology and ...
Different regions have distinct healthcare systems, varying access levels, reimbursement models, and treatment realities — ...
As cell therapy for autoimmune disease transitions from breakthrough clinical case studies to broad clinical validation, developers are racing to overcome challenges around safety, scalability, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results